Star Therapeutics

News

Incyte gobbles up Star's Vega haematology unit in $2bn deal

Incyte has agreed to buy Star Therapeutics' Vega subsidiary for $1.25bn upfront, adding a late-stage drug candidate for bleeding disorder VWD.

News

Bar graph of gold coins increasing from left to right, with plants growing out the top

Crystalys emerges with $205m, and other biofinancings

Recent biotech financings include big rounds for Crystalys and Star Therapeutics, with Sparrow, Avenzo, and Aerska also raising new funds.

News

Apollo, Nimbus lead bumper week for biotech financings

This week saw a series of big-ticket funding rounds for biotech companies, with Apollo Therapeutics and Nimbus Therapeutics both pulling in upwards of $200 million, in a p

Incyte gobbles up Star's Vega haematology unit in $2bn deal

Crystalys emerges with $205m, and other biofinancings

Apollo, Nimbus lead bumper week for biotech financings

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks